Hypolipidemic Agents

4 trials

Sponsors

Center of Natural Products, National Center for Scientific Research, National Center for Scientific Research, National Centre for Scientific Research (CNIC)

Conditions

Arterial hypertensionIschemic stroke Ischemic strokeIschemic stroke cerebral ictusMetabolic Syndrome and ischaemic cardiopaty

Phase 4

Policosanol in patients with metabolic syndrome and ischaemic cardiopaty

Active, not recruitingRPCEC00000227

Center of Natural Products, National Center for Scientific ResearchMetabolic Syndrome and ischaemic cardiopaty

Start: 2017-01-15Target: 100Updated: 2026-09-14

Policosanol in patients with pre-hypertension or with grade I hypertension

Active, not recruitingRPCEC00000377

National Center for Scientific ResearchArterial hypertension

Start: 2021-09-01Updated: 2026-08-10

Policosanol + aspirin in post-stroke cognitive impairment

Active, not recruitingRPCEC00000378

National Center for Scientific ResearchIschemic stroke cerebral ictus

Start: 2021-09-01Target: 100Updated: 2026-08-10

Policosanol on cognitive impairment after ischemic stroke

Active, not recruitingRPCEC00000475

National Centre for Scientific Research (CNIC)Ischemic stroke Ischemic stroke

Start: 2026-06-01Target: 100Updated: 2026-09-14

Related Papers

Policosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double-Blind, Multicenter Study.

2025-10-01